浏览全部资源
扫码关注微信
北京市昌平区中医医院脾胃病科,北京 102200
张娇,女,35岁,硕士,主治医师。研究方向:中西医结合防治消化系统疾病。
陶源,E-mail:taotaowzx@163.com
收稿日期:2024-08-13,
纸质出版日期:2025-04-25
移动端阅览
张娇,顾树江,邢凯,等.结肠水疗仪中药灌肠联合美沙拉嗪治疗活动期溃疡性结肠炎的疗效与预后观察[J].北京中医药,2025,44(4):430-434.
ZHANG Jiao,GU Shujiang,XING Kai,et al.Efficacy and prognosis observation of Chinese medicine enema via colon hydrotherapy device combined with mesalazine in treatment of active ulcerative colitis[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(04):430-434.
张娇,顾树江,邢凯,等.结肠水疗仪中药灌肠联合美沙拉嗪治疗活动期溃疡性结肠炎的疗效与预后观察[J].北京中医药,2025,44(4):430-434. DOI: 10.16025/j.1674-1307.2025.04.008.
ZHANG Jiao,GU Shujiang,XING Kai,et al.Efficacy and prognosis observation of Chinese medicine enema via colon hydrotherapy device combined with mesalazine in treatment of active ulcerative colitis[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(04):430-434. DOI: 10.16025/j.1674-1307.2025.04.008.
目的
2
观察结肠水疗仪中药灌肠联合美沙拉嗪治疗活动期溃疡性结肠炎的疗效与预后情况。
方法
2
选取2021年1月—2023年10月在本院收治的活动期溃疡性结肠炎患者90例进行前瞻性研究,根据随机数字表法将其分为对照组和观察组,各45例。2组均给予常规治疗,另外对照组给予美沙拉嗪肠溶片口服,1 g/次,4 次/d;观察组在对照组基础上给予结肠水疗仪中药灌肠治疗,1次/d,14 d后休息2 d。2组均连续治疗3个月。对比2组证候疗效、复发率、不良反应,治疗前后中医证候积分、血清炎症因子[白细胞介素-8(IL-8)、肿瘤坏死因子α(TNF-α)、超敏C反应蛋白(hs-CRP)]、Baron分级、Sutherland疾病活动指数(DAI)评分、改良Mayo评分。
结果
2
观察组总有效率高于对照组(
P
<
0.05),复发率低于对照组(
P
<
0.01)。与治疗前比较,2组治疗后各项中医证候积分均降低(
P
<
0.05);治疗后观察组各项中医证候积分均低于对照组(
P
<
0.05)。与治疗前比较,2组治疗后血清IL-8、TNF-α、hs-CRP水平均降低(
P
<
0.05);治疗后观察组血清IL-8、TNF-α、hs-CRP水平均低于对照组(
P
<
0.05)。与治疗前比较,治疗后2组Baron评分、DAI评分、Mayo评分均降低(
P
<
0.05);观察组Baron评分、DAI评分、Mayo评分均低于对照组(
P
<
0.05)。2组不良反应发生情况比较,差异无统计学意义(
P
>
0.05)。
结论
2
结肠水疗仪中药灌肠联合美沙拉嗪治疗活动期溃疡性结肠炎患者疗效显著、复发率低,可有效改善临床症状,减轻炎症反应。
Objective
2
To observe the efficacy and prognosis of Chinese medicine enema via colon hydrotherapy device combined with mesalazine in the treatment of active ulcerative colitis.
Methods
2
A total of 90 patients with active ulcerative colitis, who were treated at our hospital from January 2021 to October 2023, were selected for a prospective study. They were randomly divided into the control group and the observation group according to a random number table, with 45 cases in each group. Both groups received routine treatment, and the control group was additionally given mesalazine enteric-coated tablets orally (1 g per dose,4 times per day). The observation group, on the basis of the control group's treatment, was given Chinese medicine enema via colon hydrotherapy device (once per day,for 14 days,followed by a 2-day rest period).Both groups were treated continuously for 3 months. The efficacy of treatment, recurrence rate, adverse reactions, changes in traditional Chinese medicine(TCM) syndrome scores, serum inflammatory factors[interleukin-8(IL-8), tumor necrosis factor-α(TNF-α), hypersensitive C-reactive protein(hs-CRP)], Baron classification, Sutherland Disease Activity Index(DAI), and Modified Mayo score were compared before and after treatment.
Results
2
The total effective rate in the observation group was significantly higher than that in the control group(
P
<
0.05), and the recurrence rate was significantly lower in the observation group(
P
<
0.01). Compared with baseline, the TCM syndrome scores in both groups decreased after treatment(
P
<
0.05), and the scores in the observation group were significantly lower than those in the control group(
P
<
0.05). After treatment, the serum levels of IL-8, TNF-α, and hs-CRP were significantly
reduced in both groups(
P
<
0.05), with the observation group showing significantly lower levels than the control group(
P
<
0.05). The Baron score, DAI, and Mayo scores all decreased significantly after treatment in both groups(
P
<
0.05), and the observation group had significantly lower scores than the control group (
P
<
0.05). There was no significant difference in the incidence of adverse reactions between the two groups(
P
>
0.05).
Conclusion
2
Chinese medicine enema via colon hydrotherapy device combined with mesalazine is highly effective in treating active ulcerative colitis, with a low recurrence rate. It can significantly improve clinical symptoms and reduce inflammatory responses.
DU L , HA C . Epidemiology and pathogenesis of ulcerative colitis [J ] . Gastroenterol Clin North Am , 2020 , 49 ( 4 ): 643 - 654 .
万健 , 张玉洁 , 王敏 , 等 . 溃疡性结肠炎相关异型增生和溃疡性结肠炎相关性结直肠癌56例的临床特征 [J ] . 中华消化杂志 , 2021 , 41 ( 10 ): 660 - 664 .
高艳奎 , 申睿 , 朱向东 , 等 . 中医药治疗溃疡性结肠炎作用机制研究进展 [J ] . 中医药学报 , 2020 , 48 ( 2 ): 75 - 80 .
麦尔巴哈·米吉提 , 王佳佳 , 迟莉 , 等 . 中医药治疗溃疡性结肠炎研究进展 [J ] . 时珍国医国药 , 2019 , 30 ( 3 ): 669 - 671 .
杜平 , 梁仲惠 . 结肠水疗治疗活动期溃疡性结肠炎疗效观察 [J ] . 中国现代医学杂志 , 2008 , 18 ( 10 ): 1415 - 1416,1419 .
中华医学会消化病学分会炎症性肠病学组 . 炎症性肠病诊断与治疗的共识意见(2018年.北京) [J ] . 中华内科杂志 , 2018 , 38 ( 9 ): 796 - 813 .
中华中医药学会脾胃病分会 . 溃疡性结肠炎中医诊疗专家共识意见(2017) [J ] . 中华中医药杂志 , 2017 , 32 ( 8 ): 3585 - 3589 .
徐呈超 , 李旭豪 , 李金玲 . 不同针法治疗慢性肩关节周围炎的疗效及复发率的对比研究 [J ] . 针刺研究 , 2024 , 49 ( 2 ): 164 - 170 .
郑莜萸 . 中药新药临床研究指导原则(试行) [M ] . 北京 : 中国医药科技出版社 , 2002 .
BARON J H , CONNELL AM , LENNARDJ . Variation between observers in describing mucosal apperances in proctocolitis [J ] . BMJ , 1964 , 1 ( 5375 ): 89 - 92 .
PARIKH A , LEACH T , WYANT T , et al . Vedolizumab for the treatment of active ulcerative colitis:a randomized controlled phase 2dose - ranging study [J ] . Inflamm Bowel Dis , 2012 , 18 ( 8 ): 1470 - 1479 .
KUCHARZIK T , KOLETZKO S , KANNENGIESSER K , et al . Ulcerative colitis-diagnostic and therapeutic algorithms [J ] . Dtsch Arztebl Int , 2020 , 117 ( 33-34 ): 564 - 574 .
姜璐 , 吴波 , 郭良清 , 等 . 愈溃凉血颗粒联合美沙拉嗪对溃疡性结肠炎患者疗效及肠道屏障功能影响 [J ] . 辽宁中医药大学学报 , 2020 , 22 ( 4 ): 139 - 142 .
沈洪 , 邢敬 , 朱磊 , 等 . 炎症性肠病中西医结合治疗策略的探索与实践 [J ] . 北京中医药 , 2020 , 39 ( 3 ): 191 - 195 .
朱曦含 , 邓鑫 , 王澍青 , 等 . 溃疡性结肠炎复发因素分析及中医防治策略 [J ] . 北京中医药 , 2022 , 41 ( 9 ): 968 - 970 .
刘苗 , 申睿 , 谈望晶 , 等 . 中医药治疗溃疡性结肠炎研究进展 [J ] . 西部中医药 , 2019 , 32 ( 5 ): 139 - 142 .
党中勤 , 党志博 , 王宇亮 , 等 . 健脾清肠汤内服联合愈疡灌肠方保留灌肠治疗慢性持续型溃疡性结肠炎活动期患者31例临床观察 [J ] . 中医杂志 , 2015 , 56 ( 17 ): 1487 - 1490 .
陈伟 , 曹春宇 , 黎运呈 , 等 . 美沙拉嗪联合双歧杆菌三联活菌治疗溃疡性结肠炎患者的疗效分析 [J ] . 中国生化药物杂志 , 2017 , 37 ( 3 ): 90 - 91,94 .
王小凤 , 李维 . 结肠水疗仪中药灌肠治疗高脂血症32例护理体会 [J ] . 航空航天医学杂志 , 2013 , 24 ( 6 ): 753 - 754 .
于毅 , 李小飞 , 张淼 , 等 . 清化敛疡方保留灌肠联合美沙拉嗪治疗溃疡性结肠炎的临床疗效观察 [J ] . 中医药学报 , 2024 , 52 ( 7 ): 71 - 75 .
郭二涛 . 美沙拉嗪联合双歧杆菌四联活菌治疗溃疡性结肠炎的疗效及对氧化应激、炎症指标的影响 [J ] . 药品评价 , 2020 , 17 ( 15 ): 47 - 49 .
常越 , 陈希 , 田永 , 等 . 双歧杆菌三联活菌联合美沙拉嗪治疗UC患者的效果及对肠道生物屏障的影响 [J ] . 华夏医学 , 2021 , 34 ( 3 ): 69 - 73 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构